| Name | Title | Contact Details |
|---|
Since its beginning in 2007 as a technical staffing and business solutions group in Annapolis, Md., Syndicus has evolved into a highly respected technical staffing and consulting solutions group that provides talent and solutions for three focus areas: Health Information Technology, Life Sciences Solutions and Technology Services. We pride ourselves in partnering with top subject matter experts who ensure candidates, consultants and solutions meet clients' specialized needs. In 2012, Syndicus achieved both a full national accreditation with the Management Services Organization Accreditation Program (MSOAP) from the Electronic Healthcare Network Accreditation Commission (EHNAC) and the MSO State Designation from the Maryland Health Care Commission (MHCC). The two certifications enable Syndicus and its electronic health records (EHR) hosted solutions provider eCast Corporation to continue working with Maryland healthcare providers on EHR adoption efforts – and subsequent achievement of Meaningful Use.
Nutracea, Inc. is a Paradise Valley, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OmniSYS-LLC is a Greenville, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Prime Medica is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Personal Genome Diagnostics (PGDx) is a provider of advanced technology solutions based on Next Generation Sequencing (NGS) and related technologies for cancer genome analysis. PGDx has developed proprietary techniques that identify mutations found in a patient`s tumor through noninvasive testing of circulating tumor DNA. This allows for characterization of unique aspects of disease, such as detection and monitoring of cancer, as well as, identification of mechanisms of resistance to targeted therapy. PGDx is CLIA certified for high-complexity molecular testing using whole exome and targeted analysis approaches. Research and custom approaches include whole genome, exome, custom capture, targeted and plasma analysis. PGDx has developed and introduced a number of proprietary methods to study blood and tissue tumor samples, including methods for advanced bioinformatics analysis.